Wells Fargo & Company Surgalign Holdings, Inc. Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$0.18 - $1.65 $1,785 - $16,371	-9,922 Reduced 98.81%	119 $0
Q1 2023 May 12, 2023	SELL	$1.57 - $2.79 $9 - $16	-6 Reduced 0.06%	10,041 $16,000
Q4 2022 Feb 13, 2023	SELL	$1.36 - $3.9 $223 - $639	-164 Reduced 1.61%	10,047 $19,000
Q3 2022 Nov 14, 2022	BUY	$3.01 - $6.0 $10,544 - $21,018	3,503 Added 52.22%	10,211 $35,000
Q2 2022 Aug 12, 2022	BUY	$3.38 - $9.0 $22,673 - $60,372	6,708 New	6,708 $23,000

Ticker SRGA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,746,500
Market Cap $67.5K
Description
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.